Paper32797366
Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place.
van Hoeve K and 1 other. Paediatr Drugs, 2020. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place. Papers, record 32797366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32797366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Immunologic Factors | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Purines | Major topic |
| Thionucleosides | Major topic |
| Child | |
| Drug Therapy, Combination | |
| Humans |
Source PubMed
References138
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12065760 | The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs. | Mol Pharmacol | 2002 | https://conductscience.org/library/papers/12065760 | PubMed |
| 2 | 30633088 | Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease. | Ther Drug Monit | 2019 | https://conductscience.org/library/papers/30633088 | PubMed |
| 3 | 24991785 | Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease. | Inflamm Bowel Dis | 2014 | https://conductscience.org/library/papers/24991785 | PubMed |
| 4 | 25066841 | Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease. | Clin Gastroenterol Hepatol | 2015 | https://conductscience.org/library/papers/25066841 | PubMed |
| 5 | 5788533 | Inhibition of phosphoribosyl pyrophosphate amidotransferase from Ehrlich ascites-tumour cells by thiopurine nucleotides. | Biochem Pharmacol | 1969 | https://conductscience.org/library/papers/5788533 | PubMed |
| 6 | 19821389 | Interventions for prevention of post-operative recurrence of Crohn's disease. | Cochrane Database Syst Rev | 2009 | https://conductscience.org/library/papers/19821389 | PubMed |
| 7 | 27271489 | Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis. | Inflamm Bowel Dis | 2016 | https://conductscience.org/library/papers/27271489 | PubMed |
| 8 | 24162032 | Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease. | Gastroenterology | 2014 | https://conductscience.org/library/papers/24162032 | PubMed |
| 9 | 18306311 | Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. | Inflamm Bowel Dis | 2008 | https://conductscience.org/library/papers/18306311 | PubMed |
| 10 | 29202588 | Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease. | Expert Opin Drug Saf | 2018 | https://conductscience.org/library/papers/29202588 | PubMed |
| 11 | 16618398 | Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. | Gastroenterology | 2006 | https://conductscience.org/library/papers/16618398 | PubMed |
| 12 | 7191632 | Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. | Am J Hum Genet | 1980 | https://conductscience.org/library/papers/7191632 | PubMed |
| 13 | 21224840 | Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. | Am J Gastroenterol | 2011 | https://conductscience.org/library/papers/21224840 | PubMed |
| 14 | 23128233 | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | Nature | 2012 | https://conductscience.org/library/papers/23128233 | PubMed |
| 15 | 22784257 | Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism. | Aliment Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22784257 | PubMed |
| 16 | 20626362 | Infliximab therapy in children with Crohn's disease: a one-year evaluation of efficacy comparing 'top-down' and 'step-up' strategies. | Acta Paediatr | 2011 | https://conductscience.org/library/papers/20626362 | PubMed |
| 17 | 20393175 | Infliximab, azathioprine, or combination therapy for Crohn's disease. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20393175 | PubMed |
| 18 | 21910176 | Tolerance and efficacy of azathioprine in pediatric Crohn's disease. | Inflamm Bowel Dis | 2011 | https://conductscience.org/library/papers/21910176 | PubMed |
| 19 | 10208641 | The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. | Pharmacogenetics | 1999 | https://conductscience.org/library/papers/10208641 | PubMed |
| 20 | 12030954 | Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey. | Aliment Pharmacol Ther | 2002 | https://conductscience.org/library/papers/12030954 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42746383 | PACSIN2 regulates mercaptopurine cytotoxicity and cellular biomechanics through Rac1 modulation in intestinal epithelial cells. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42746383 | PubMed |
| 41292289 | Comparative risk of serious infection among biologic therapies for inflammatory bowel disease in pediatric patients: A target trial emulation. | J Pediatr Gastroenterol Nutr | 2026 | https://conductscience.org/library/papers/41292289 | PubMed |
| 41200039 | Stimuli-responsive nanomaterials for targeted drug delivery in inflammatory bowel disease: Advances and emerging directions. | Matter | 2025 | https://conductscience.org/library/papers/41200039 | PubMed |
| 40682730 | Clinical utility of thiopurine metabolite levels in monitoring patients with inflammatory bowel disease: A single-centre retrospective study. | Indian J Gastroenterol | 2026 | https://conductscience.org/library/papers/40682730 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TPMT | 7172 | PubTator's text mining | https://conductscience.org/library/genes/7172 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32797366
GET https://conductscience.org/api/papers/v1/32797366/references?page=2